Engineered immune cells aim to keep HIV in check without daily pills

NCT ID NCT06252402

First seen Feb 24, 2026 · Last updated May 25, 2026 · Updated 9 times

Summary

This study tests a new treatment for people with HIV that uses their own immune cells, modified to recognize and attack HIV. The goal is to see if these special cells can stay active in the body and help control the virus, possibly allowing participants to stop daily antiretroviral therapy. The trial involves 15 adults with well-controlled HIV and aims to check safety and feasibility first.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

    Contact

  • UCSD, Division of Infectious Diseases and Global Public Health

    RECRUITING

    San Diego, California, 92093, United States

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.